Logo image of BYND

BEYOND MEAT INC (BYND) Stock Fundamental Analysis

NASDAQ:BYND - Nasdaq - US08862E1091 - Common Stock - Currency: USD

3.16  -0.11 (-3.36%)

After market: 3.16 0 (0%)

Fundamental Rating

2

BYND gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 89 industry peers in the Food Products industry. BYND may be in some trouble as it scores bad on both profitability and health. BYND does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BYND had negative earnings in the past year.
BYND had a negative operating cash flow in the past year.
In the past 5 years BYND always reported negative net income.
BYND had a negative operating cash flow in each of the past 5 years.
BYND Yearly Net Income VS EBIT VS OCF VS FCFBYND Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

The Return On Assets of BYND (-24.67%) is worse than 82.02% of its industry peers.
Industry RankSector Rank
ROA -24.67%
ROE N/A
ROIC N/A
ROA(3y)-33.92%
ROA(5y)-25.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BYND Yearly ROA, ROE, ROICBYND Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

Looking at the Gross Margin, with a value of 11.57%, BYND is doing worse than 68.54% of the companies in the same industry.
BYND's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for BYND so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.31%
GM growth 5Y-17.54%
BYND Yearly Profit, Operating, Gross MarginsBYND Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

BYND does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BYND has been increased compared to 1 year ago.
BYND has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BYND is higher compared to a year ago.
BYND Yearly Shares OutstandingBYND Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BYND Yearly Total Debt VS Total AssetsBYND Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -2.68, we must say that BYND is in the distress zone and has some risk of bankruptcy.
BYND has a worse Altman-Z score (-2.68) than 80.90% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.68
ROIC/WACCN/A
WACC6.06%
BYND Yearly LT Debt VS Equity VS FCFBYND Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

A Current Ratio of 3.39 indicates that BYND has no problem at all paying its short term obligations.
BYND's Current ratio of 3.39 is amongst the best of the industry. BYND outperforms 86.52% of its industry peers.
A Quick Ratio of 2.07 indicates that BYND has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.07, BYND belongs to the top of the industry, outperforming 86.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.39
Quick Ratio 2.07
BYND Yearly Current Assets VS Current LiabilitesBYND Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.52% over the past year.
BYND shows a decrease in Revenue. In the last year, the revenue decreased by -2.17%.
BYND shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.85% yearly.
EPS 1Y (TTM)36.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.94%
Revenue 1Y (TTM)-2.17%
Revenue growth 3Y-11.1%
Revenue growth 5Y1.85%
Sales Q2Q%-9.09%

3.2 Future

Based on estimates for the next years, BYND will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.90% on average per year.
The Revenue is expected to grow by 2.31% on average over the next years.
EPS Next Y26.15%
EPS Next 2Y19.23%
EPS Next 3Y17.56%
EPS Next 5Y16.9%
Revenue Next Year-5.7%
Revenue Next 2Y-1.27%
Revenue Next 3Y0.43%
Revenue Next 5Y2.31%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BYND Yearly Revenue VS EstimatesBYND Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
BYND Yearly EPS VS EstimatesBYND Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -2 -4 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BYND reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BYND is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BYND Price Earnings VS Forward Price EarningsBYND Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BYND Per share dataBYND EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 -6 -8

4.3 Compensation for Growth

BYND's earnings are expected to grow with 17.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.23%
EPS Next 3Y17.56%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BYND!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BEYOND MEAT INC

NASDAQ:BYND (6/13/2025, 7:41:27 PM)

After market: 3.16 0 (0%)

3.16

-0.11 (-3.36%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners43.51%
Inst Owner Change-0.52%
Ins Owners4.57%
Ins Owner Change9.21%
Market Cap241.65M
Analysts47.5
Price Target2.96 (-6.33%)
Short Float %40.85%
Short Ratio13.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-41.27%
Min EPS beat(2)-46.83%
Max EPS beat(2)-35.72%
EPS beat(4)1
Avg EPS beat(4)-18.93%
Min EPS beat(4)-46.83%
Max EPS beat(4)9.47%
EPS beat(8)2
Avg EPS beat(8)-12.35%
EPS beat(12)4
Avg EPS beat(12)-11.65%
EPS beat(16)4
Avg EPS beat(16)-26.24%
Revenue beat(2)0
Avg Revenue beat(2)-5.58%
Min Revenue beat(2)-10.16%
Max Revenue beat(2)-1%
Revenue beat(4)1
Avg Revenue beat(4)-2.18%
Min Revenue beat(4)-10.16%
Max Revenue beat(4)4.04%
Revenue beat(8)2
Avg Revenue beat(8)-2.87%
Revenue beat(12)3
Avg Revenue beat(12)-3.4%
Revenue beat(16)4
Avg Revenue beat(16)-3.01%
PT rev (1m)-20.94%
PT rev (3m)-29.22%
EPS NQ rev (1m)-0.36%
EPS NQ rev (3m)-22.27%
EPS NY rev (1m)-8.25%
EPS NY rev (3m)-9.17%
Revenue NQ rev (1m)-12.26%
Revenue NQ rev (3m)-14.16%
Revenue NY rev (1m)-2.5%
Revenue NY rev (3m)-7.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.76
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.26
EYN/A
EPS(NY)-1.34
Fwd EYN/A
FCF(TTM)-1.41
FCFYN/A
OCF(TTM)-1.22
OCFYN/A
SpS4.18
BVpS-8.49
TBVpS-8.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.57%
FCFM N/A
ROA(3y)-33.92%
ROA(5y)-25.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.31%
GM growth 5Y-17.54%
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 60.69%
Cap/Sales 4.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.39
Quick Ratio 2.07
Altman-Z -2.68
F-Score4
WACC6.06%
ROIC/WACCN/A
Cap/Depr(3y)98.2%
Cap/Depr(5y)297.95%
Cap/Sales(3y)7.98%
Cap/Sales(5y)14.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.94%
EPS Next Y26.15%
EPS Next 2Y19.23%
EPS Next 3Y17.56%
EPS Next 5Y16.9%
Revenue 1Y (TTM)-2.17%
Revenue growth 3Y-11.1%
Revenue growth 5Y1.85%
Sales Q2Q%-9.09%
Revenue Next Year-5.7%
Revenue Next 2Y-1.27%
Revenue Next 3Y0.43%
Revenue Next 5Y2.31%
EBIT growth 1Y52.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.28%
EBIT Next 3Y19.88%
EBIT Next 5Y20.25%
FCF growth 1Y57.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.76%
OCF growth 3YN/A
OCF growth 5YN/A